Alkermes plc. Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit
Alkermes plc. (ALKS) had Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit of $7.20 million as of 2013-03-31, per its 10-K filed 2013-05-23.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit · last filed 2013-05-23
- 2013-03-31: Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit $7.20M.
- 2012-03-31: Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit $500.00K.
| Period end | Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit |
|---|---|
| 2013-03-31 | $7.20M 10-K · filed 2013-05-23 |
| 2012-03-31 | $500.00K 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |